Clinical Trials on Unresectable Locally Advanced

Total 9416 results

NRT MedTech Australia Pty Ltd

Not yet recruiting

Safety and Efficacy of NRT6008 Administered in Combination With Chemotherapy in Patients With Unresectable Locally Advanced Pancreatic Carcinoma (LAPC)

Unresectable Locally Advanced Pancreatic Carcinoma

Australia
Shanghai Runshi Pharmaceutical Technology Co., Ltd
Jilin Provincial Tumor Hospital

Recruiting

A Study to Investigate the Safety of SYHA1815 in Subjects With Unresectable Locally Advanced or Metastatic Solid Tumors

Locally Advanced Unresectable Carcinoma

China
Gilead Sciences
Everest Medicines

Completed

Study of Sacituzumab Govitecan Versus Physician's Choice of Treatment in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread (TROPiCS-04)

Locally Advanced or Metastatic Unresectable Urothelial Cancer

United States, France, Spain, United Kingdom, Taiwan, Israel, Czechia, Germany, China, Italy, Australia, Hong Kong, Portugal, Singapore, Croatia, Belgium, Greece, Sweden, Switzerland, Canada, Austria, Bulgaria, Georgia, Ireland, South Korea and more
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Terminated

First-in-Human Study of MS201408-0005A as Single Agent and in Combinations

Metastatic or Locally Advanced Unresectable Solid Tumors

United States
Shenyang Sunshine Pharmaceutical Co., LTD.

Recruiting

SSGJ-705 Plus SSGJ-612 ± Chemotherapy in Advanced HER2-Expressing Solid Tumors

Locally Advanced (Unresectable) or Metastatic Solid Tumors

China

This is a preview

Log in or create a free account to see all matching trials and use the full search.

Log in Register

Subscribe